Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 8-K Event Delisting notice
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  16. EFFECT Other Notice of Effectiveness
  17. 8-K Event Delisting notice
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. 4 Open-market buy Director bought 536,426 shares at an average $0.91 ($487,188)
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 11 of 23 · 453 filings